$BLFS
BIOLIFE SOLUTIONS INC Stock $blfs

$blfs Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000162828024022690 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$28.33M	$31.73M	$37.70M
YoY Change	-28.3%	-15.85%	4.09%
Cost Of Revenue	$13.44M	$19.17M	$23.66M
YoY Change	-51.49%	-19.01%	-3.2%
Gross Profit	$14.89M	$12.56M	$14.04M
YoY Change	26.08%	-10.53%	19.24%
Gross Profit Margin	52.57%	39.59%	37.24%
Selling, General & Admin	$14.40M	$18.00M	$21.31M
YoY Change	-33.72%	-15.53%	32.49%
% of Gross Profit	96.66%	143.33%	151.81%
Research & Development	$2.382M	$3.534M	$4.152M
YoY Change	-50.79%	-14.88%	9.81%
% of Gross Profit	15.99%	28.13%	29.57%
Depreciation & Amortization	$600.0K	$1.364M	$1.721M
YoY Change	-40.0%	-20.74%	4.11%
% of Gross Profit	4.03%	10.86%	12.26%
Operating Expenses	$16.78M	$21.54M	$25.47M
YoY Change	-36.83%	-15.42%	28.17%
Operating Profit	-$2.795M	-$10.13M	-$13.61M
YoY Change	-81.71%	-25.56%	78.24%
Interest Expense	-$361.0K	-$207.0K	-$411.0K
YoY Change	-13.84%	-49.64%	152.15%
% of Operating Profit
Other Income/Expense, Net	-$4.351M	$38.00K	-$17.00K
YoY Change	-185.55%	-323.53%	-46.88%
Pretax Income	-$7.146M	-$10.09M	-$13.62M
YoY Change	-29.9%	-25.93%	77.72%
Income Tax	$0.00	$100.0K	$92.00K
% Of Pretax Income
Net Earnings	-$20.72M	-$10.22M	-$13.71M
YoY Change	103.15%	-25.47%	94.08%
Net Earnings / Revenue	-73.14%	-32.22%	-36.37%
Basic Earnings Per Share	-$0.45	-$0.22	-$0.32
Diluted Earnings Per Share	-$0.45	-$0.22	-$0.32
COMMON SHARES
Basic Shares Outstanding	46.03M shares	45.30M shares	43.21M
Diluted Shares Outstanding	46.00M shares	45.43M shares	43.03M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$34.13M	$45.27M	$54.89M
YoY Change	-26.21%	-17.51%	-7.7%
Cash & Equivalents	$22.01M	$29.69M	$19.11M
Short-Term Investments	$12.12M	$15.58M	$35.78M
Other Short-Term Assets	$15.63M	$20.02M	$42.01M
YoY Change	-52.47%	-52.35%	781.31%
Inventory	$32.50M	$43.41M	$41.33M
Prepaid Expenses
Receivables	$18.06M	$18.57M	$30.34M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$88.20M	$111.7M	$132.8M
YoY Change	-26.69%	-15.88%	11.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.26M	$21.04M	$26.10M
YoY Change	-32.5%	-19.38%	42.94%
Goodwill	$224.7M	$224.7M	$224.7M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$19.33M	$20.24M	$30.63M
YoY Change	-33.77%	-33.94%	-79.48%
Long-Term Investments	$995.0K	$5.069M	$5.069M
YoY Change	-80.37%	0.0%	15.94%
Other Assets	$2.929M	$1.067M	$2.303M
YoY Change	35.92%	-53.67%	769.06%
Total Long-Term Assets	$286.8M	$289.9M	$313.7M
YoY Change	-8.34%	-7.58%	-26.25%
TOTAL ASSETS
Total Short-Term Assets	$88.20M	$111.7M	$132.8M
Total Long-Term Assets	$286.8M	$289.9M	$313.7M
Total Assets	$375.0M	$401.6M	$446.5M
YoY Change	-13.44%	-10.05%	-17.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.213M	$4.984M	$15.53M
YoY Change	-60.57%	-67.9%	32.57%
Accrued Expenses	$2.798M	$4.253M	$3.825M
YoY Change	-23.82%	11.19%	178.79%
Deferred Revenue	$640.0K	$299.0K	$422.0K
YoY Change	66.23%	-29.15%	-52.85%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$10.61M	$8.619M	$1.250M
YoY Change	448.53%	589.52%	124.42%
Total Short-Term Liabilities	$30.82M	$38.66M	$47.32M
YoY Change	-22.15%	-18.3%	35.04%
LONG-TERM LIABILITIES
Long-Term Debt	$10.45M	$15.68M	$23.69M
YoY Change	-55.66%	-33.81%	275.29%
Other Long-Term Liabilities	$11.08M	$12.58M	$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$10.45M	$15.68M	$23.69M
YoY Change	-55.66%	-33.81%	271.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$30.82M	$38.66M	$47.32M
Total Long-Term Liabilities	$10.45M	$15.68M	$23.69M
Total Liabilities	$53.53M	$68.20M	$88.36M
YoY Change	-33.95%	-22.82%	34.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$345.9M	-$325.1M	-$260.6M
YoY Change	27.7%	24.75%	132.53%
Common Stock	$667.9M	$659.1M	$619.3M
YoY Change	7.12%	6.43%	4.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$321.4M	$333.4M	$358.1M
YoY Change
Total Liabilities & Shareholders Equity	$375.0M	$401.6M	$446.5M
YoY Change	-13.44%	-10.05%	-17.93%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$20.72M	-$10.22M	-$13.71M
YoY Change	103.15%	-25.47%	94.08%
Depreciation, Depletion And Amortization	$600.0K	$1.364M	$1.721M
YoY Change	-40.0%	-20.74%	4.11%
Cash From Operating Activities	$6.459M	-$4.475M	-$2.712M
YoY Change	-183.69%	65.01%	-65.77%
INVESTING ACTIVITIES
Capital Expenditures	$15.16M	$820.0K	$3.295M
YoY Change	602.04%	-75.11%	126.3%
Acquisitions
YoY Change
Other Investing Activities	$1.729M	$599.0K	$7.222M
YoY Change	-84.9%	-91.71%
Cash From Investing Activities	-$13.44M	-$221.0K	$2.926M
YoY Change	-244.59%	-107.55%	-228.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-704.0K	-$952.0K	-$562.0K
YoY Change	-200.0%	69.4%	210.5%
NET CHANGE
Cash From Operating Activities	6.459M	-$4.475M	-$2.712M
Cash From Investing Activities	-13.44M	-$221.0K	$2.926M
Cash From Financing Activities	-704.0K	-$952.0K	-$562.0K
Net Change In Cash	-7.680M	-$5.648M	-$348.0K
YoY Change	-437.14%	1522.99%	-96.65%
FREE CASH FLOW
Cash From Operating Activities	$6.459M	-$4.475M	-$2.712M
Capital Expenditures	$15.16M	$820.0K	$3.295M
Free Cash Flow	-$8.705M	-$5.295M	-$6.007M
YoY Change	-11.87%	-11.85%	-35.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Assets Current AssetsCurrent	111700000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	120604000	usd
CY2024Q1	blfs	Assets Held For Rent Net AssetsHeldForRentNet	6904000	usd
CY2023Q4	blfs	Assets Held For Rent Net AssetsHeldForRentNet	7713000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21042000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21077000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10779000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11446000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	65000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	94000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4984000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6940000	usd
CY2024Q1	blfs	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	8863000	usd
CY2023Q4	blfs	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	11932000	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	5395000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	5442000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	7800000	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	245000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	273000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Noncurrent DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossNoncurrent	822000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Noncurrent DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossNoncurrent	548000	usd
CY2024Q1	blfs	Equity Investments EquityInvestments	5069000	usd
CY2023Q4	blfs	Equity Investments EquityInvestments	5069000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20235000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	21149000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	224741000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	224741000	usd
CY2024Q1	us-gaap	Assets Assets	401602000	usd
CY2023Q4	us-gaap	Assets Assets	412714000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	7858000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2645000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2797000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	352000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	376000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	8619000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6833000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	38658000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	42178000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12579000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13205000	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1086000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1169000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15681000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	18311000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	193000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	188000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	68197000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	75051000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45689583	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45689583	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45167225	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45167225	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	46000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	45000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	659063000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	652880000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-566000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-345000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-325138000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-314917000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	333405000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	337663000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	401602000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	412714000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	31727000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	37703000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12934000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14842000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5070000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6471000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3534000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4152000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	914000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1459000	usd
CY2024Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	237000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	720000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	41855000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	51308000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10128000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-13605000	usd
CY2024Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-207000	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-411000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	245000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	394000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	38000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10090000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13622000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	131000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	92000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-10221000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13714000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10221000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10221000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-13714000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13714000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45432426	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45432426	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43027612	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43027612	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-10221000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13714000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-203000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	106000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-18000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	39000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10442000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13569000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	337663000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6183000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-203000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-18000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-10221000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	333405000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	364188000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7363000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	125000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	106000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	39000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	358107000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-10221000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13714000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1364000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1721000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	914000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1459000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	13000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6183000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7363000	usd
CY2024Q1	blfs	Noncash Lease Expense NoncashLeaseExpense	-83000	usd
CY2023Q1	blfs	Noncash Lease Expense NoncashLeaseExpense	418000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	13000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	720000	usd
CY2024Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	182000	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	390000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	14000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-68000	usd
CY2024Q1	blfs	Gain Loss On Disposition Of Assets Held For Rent GainLossOnDispositionOfAssetsHeldForRent	-198000	usd
CY2023Q1	blfs	Gain Loss On Disposition Of Assets Held For Rent GainLossOnDispositionOfAssetsHeldForRent	-218000	usd
CY2024Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-50000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-65000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3612000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-42000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6425000	usd
CY2024Q1	blfs	Increase Decrease In Prepaid Expense Other Current Assets And Long Term Deposits IncreaseDecreaseInPrepaidExpenseOtherCurrentAssetsAndLongTermDeposits	-2392000	usd
CY2023Q1	blfs	Increase Decrease In Prepaid Expense Other Current Assets And Long Term Deposits IncreaseDecreaseInPrepaidExpenseOtherCurrentAssetsAndLongTermDeposits	-661000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1956000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	157000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2767000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	371000	usd
CY2024Q1	blfs	Warranty Liability WarrantyLiability	-58000	usd
CY2023Q1	blfs	Warranty Liability WarrantyLiability	583000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	20000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	510000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-377000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-20000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4475000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2712000	usd
CY2024Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	6374000	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	8202000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	973000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	524000	usd
CY2024Q1	blfs	Maturities Of Available For Sale Securities MaturitiesOfAvailableForSaleSecurities	6000000	usd
CY2023Q1	blfs	Maturities Of Available For Sale Securities MaturitiesOfAvailableForSaleSecurities	14900000	usd
CY2024Q1	blfs	Payments To Acquire Assets Held For Rent PaymentsToAcquireAssetsHeldForRent	464000	usd
CY2023Q1	blfs	Payments To Acquire Assets Held For Rent PaymentsToAcquireAssetsHeldForRent	1001000	usd
CY2024Q1	blfs	Payments For Proceeds From Property Plant And Equipment PaymentsForProceedsFromPropertyPlantAndEquipment	356000	usd
CY2023Q1	blfs	Payments For Proceeds From Property Plant And Equipment PaymentsForProceedsFromPropertyPlantAndEquipment	3295000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-221000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2926000	usd
CY2024Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	241000	usd
CY2023Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	127000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	125000	usd
CY2024Q1	blfs	Repayments Of Financed Insurance Premium RepaymentsOfFinancedInsurancePremium	727000	usd
CY2023Q1	blfs	Repayments Of Financed Insurance Premium RepaymentsOfFinancedInsurancePremium	569000	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	16000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	9000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-952000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-562000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5648000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-348000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35438000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19473000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-65000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29725000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19136000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	26000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	347000	usd
CY2024Q1	blfs	Equipment Acquired Under Operating Leases EquipmentAcquiredUnderOperatingLeases	0	usd
CY2023Q1	blfs	Equipment Acquired Under Operating Leases EquipmentAcquiredUnderOperatingLeases	880000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-6000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	18000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-39000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	445000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	497000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates and assumptions by management affect the Company’s net realizable value of inventory, sales tax liabilities, valuation of market-based stock awards, valuations, fair value of marketable debt securities, expected future cash flows including growth rates, discount rates, terminal values and other assumptions and estimates used to evaluate the recoverability of long-lived assets, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, stock-based compensation, contingent consideration from business combinations, and provision for income taxes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly assesses these estimates; however, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances.</span></div>
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	reportable_segment
CY2024Q1	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reporting_unit
CY2024Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	46100000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	52300000	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of credit risk and business risk</span></div>Significant customers are those that represent more than 10% of the Company’s total revenue or gross accounts receivable balances for the periods and as of each balance sheet date presented.
CY2024Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	15590000	usd
CY2024Q1	blfs	Debt Securities Availableforsale Unrealized Gain Current DebtSecuritiesAvailableforsaleUnrealizedGainCurrent	1000	usd
CY2024Q1	blfs	Debt Securities Available For Sale Unrealized Loss Current DebtSecuritiesAvailableForSaleUnrealizedLossCurrent	12000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	15579000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	16413000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	652880000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-314917000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	13000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	16401000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	16285000	usd
CY2023Q4	blfs	Debt Securities Availableforsale Unrealized Gain Current DebtSecuritiesAvailableforsaleUnrealizedGainCurrent	7000	usd
CY2023Q4	blfs	Debt Securities Available For Sale Unrealized Loss Current DebtSecuritiesAvailableForSaleUnrealizedLossCurrent	4000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	16288000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	16830000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	10000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	16836000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	15590000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	15579000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Noncurrent DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent	823000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	822000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	16413000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	16401000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	24330000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	26219000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6737000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	7128000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12347000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10109000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	43414000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	43456000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.043
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.043
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.084
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.083
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y2M12D
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2069000	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	245000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	15224000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	1438000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y4M24D
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M24D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y1M6D
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	804000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	897000	usd
CY2024Q1	blfs	Financing Lease Costs FinancingLeaseCosts	59000	usd
CY2023Q1	blfs	Financing Lease Costs FinancingLeaseCosts	0	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	442000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	402000	usd
CY2024Q1	blfs	Operating Lease Costs And Short Term Lease Costs OperatingLeaseCostsAndShortTermLeaseCosts	1305000	usd
CY2023Q1	blfs	Operating Lease Costs And Short Term Lease Costs OperatingLeaseCostsAndShortTermLeaseCosts	1299000	usd
CY2024Q1	us-gaap	Variable Lease Cost VariableLeaseCost	361000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	259000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	1666000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	1558000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2471000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	349000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3030000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	424000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2574000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	389000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2280000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	387000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2042000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	134000	usd
CY2024Q1	blfs	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	4896000	usd
CY2024Q1	blfs	Finance Lease Liability Payments Due After Year Four FinanceLeaseLiabilityPaymentsDueAfterYearFour	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	17293000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1683000	usd
CY2024Q1	blfs	Shippers Placed In Service ShippersPlacedInService	9709000	usd
CY2023Q4	blfs	Shippers Placed In Service ShippersPlacedInService	9866000	usd
CY2024Q1	blfs	Fixed Assets Held For Rent FixedAssetsHeldForRent	579000	usd
CY2023Q4	blfs	Fixed Assets Held For Rent FixedAssetsHeldForRent	1468000	usd
CY2024Q1	blfs	Shippers Placed In Service Accumulated Depreciation ShippersPlacedInServiceAccumulatedDepreciation	6080000	usd
CY2023Q4	blfs	Shippers Placed In Service Accumulated Depreciation ShippersPlacedInServiceAccumulatedDepreciation	6272000	usd
CY2024Q1	blfs	Shippers Placed In Service Net ShippersPlacedInServiceNet	4208000	usd
CY2023Q4	blfs	Shippers Placed In Service Net ShippersPlacedInServiceNet	5062000	usd
CY2024Q1	blfs	Shippers And Related Components In Production ShippersAndRelatedComponentsInProduction	2696000	usd
CY2023Q4	blfs	Shippers And Related Components In Production ShippersAndRelatedComponentsInProduction	2651000	usd
CY2024Q1	blfs	Shippers Placed In Service And Fixed Assets Held For Rent Net ShippersPlacedInServiceAndFixedAssetsHeldForRentNet	6904000	usd
CY2023Q4	blfs	Shippers Placed In Service And Fixed Assets Held For Rent Net ShippersPlacedInServiceAndFixedAssetsHeldForRentNet	7713000	usd
CY2024Q1	blfs	Assets Held For Rent Depreciation AssetsHeldForRentDepreciation	700000	usd
CY2023Q1	blfs	Assets Held For Rent Depreciation AssetsHeldForRentDepreciation	800000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	31729000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	30579000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10687000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9502000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21042000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21077000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	700000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	900000	usd
CY2024Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	37192000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16957000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20235000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P7Y1M6D
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	37192000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16043000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	21149000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P7Y3M18D
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	900000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1500000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2689000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3468000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3358000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2605000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1500000	usd
CY2024Q1	blfs	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	6615000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20235000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4253000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6909000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	667000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	562000	usd
CY2024Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	3644000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	3800000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	299000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	661000	usd
CY2024Q1	blfs	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	8863000	usd
CY2023Q4	blfs	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	11932000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	7858000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	8312000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	767000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1891000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	825000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1308000	usd
CY2024Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	7800000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	8895000	usd
CY2024Q1	us-gaap	Purchase Obligation PurchaseObligation	10000000	usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	5000000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	5400000	usd
CY2021Q2	blfs	Number Of Term Notes Assumed NumberOfTermNotesAssumed	3	note
CY2021Q2	blfs	Number Of Term Notes Assumed NumberOfTermNotesAssumed	3	note
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	24381000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	25242000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	81000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	98000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	24300000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	25144000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	8619000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6833000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	5975000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	10511000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5218000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2596000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2024Q1	blfs	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	0	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	24300000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	300000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	700000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	400000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	200000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	31727000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	37703000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	217250	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.21
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	217250	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.21
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	217250	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.21
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3600000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y9M18D
CY2022Q1	blfs	Number Of Peers NumberOfPeers	20	peer
CY2023Q1	blfs	Number Of Peers NumberOfPeers	20	peer
CY2024Q1	blfs	Number Of Peers NumberOfPeers	20	peer
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6183000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7363000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.012
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	600000	usd
CY2024Q1	blfs	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Without Discrete Items Percent EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateWithoutDiscreteItemsPercent	-0.018
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	54700000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-10221000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13714000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10221000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10221000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13714000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-13714000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45432426	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45432426	shares
CY2024Q1	blfs	Weighted Average Number Of Shares Issued Diluted WeightedAverageNumberOfSharesIssuedDiluted	45432426	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	45432426	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43027612	shares
CY2023Q1	blfs	Weighted Average Number Of Shares Issued Diluted WeightedAverageNumberOfSharesIssuedDiluted	43027612	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43027612	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	43027612	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3766824	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3153029	shares
CY2024Q1	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1
CY2024Q1	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	300000	usd
CY2023Q1	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	300000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-022690-index-headers.html	Edgar Link	pending
0001628280-24-022690-index.html	Edgar Link	pending
0001628280-24-022690.txt	Edgar Link	pending
0001628280-24-022690-xbrl.zip	Edgar Link	pending
blfs-20240331.htm	Edgar Link	pending
blfs-20240331.xsd	Edgar Link	pending
blfs-20240331_g1.jpg	Edgar Link	pending
exhibit311-q12024.htm	Edgar Link	pending
exhibit312-q12024.htm	Edgar Link	pending
exhibit321-q12024.htm	Edgar Link	pending
exhibit322-q12024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
blfs-20240331_def.xml	Edgar Link	unprocessable
blfs-20240331_lab.xml	Edgar Link	unprocessable
blfs-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
blfs-20240331_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
blfs-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BLFS
BIOLIFE SOLUTIONS INC Stock $blfs

2024 Q2 Form 10-Q Financial Statement

#000162828024022690 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLFS BIOLIFE SOLUTIONS INC Stock $blfs

2024 Q2 Form 10-Q Financial Statement

#000162828024022690 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLFS
BIOLIFE SOLUTIONS INC Stock $blfs